Vericel Corp. (VCEL)
43.22
+0.92
(+2.17%)
USD |
NASDAQ |
Aug 25, 16:00
43.17
-0.05
(-0.12%)
After-Hours: 19:59
Vericel Total Return Level : 43.22 for Aug. 25, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 25, 2026 | 43.22 |
| August 24, 2026 | 42.30 |
| August 21, 2026 | 42.68 |
| August 20, 2026 | 42.11 |
| August 19, 2026 | 43.57 |
| August 18, 2026 | 44.26 |
| August 17, 2026 | 43.59 |
| August 14, 2026 | 44.20 |
| August 13, 2026 | 44.54 |
| August 12, 2026 | 44.73 |
| August 11, 2026 | 44.35 |
| August 10, 2026 | 43.95 |
| August 07, 2026 | 45.09 |
| August 06, 2026 | 44.75 |
| August 05, 2026 | 45.36 |
| August 04, 2026 | 46.34 |
| August 03, 2026 | 46.05 |
| July 31, 2026 | 45.96 |
| July 30, 2026 | 47.61 |
| July 29, 2026 | 46.62 |
| July 28, 2026 | 46.71 |
| July 27, 2026 | 45.32 |
| July 24, 2026 | 45.05 |
| July 23, 2026 | 45.04 |
| July 22, 2026 | 44.56 |
| Date | Value |
|---|---|
| July 21, 2026 | 46.14 |
| July 20, 2026 | 45.88 |
| July 17, 2026 | 46.64 |
| July 16, 2026 | 47.81 |
| July 15, 2026 | 46.72 |
| July 14, 2026 | 46.09 |
| July 13, 2026 | 47.49 |
| July 10, 2026 | 47.00 |
| July 09, 2026 | 48.31 |
| July 08, 2026 | 47.02 |
| July 07, 2026 | 46.95 |
| July 06, 2026 | 46.56 |
| July 02, 2026 | 46.98 |
| July 01, 2026 | 45.15 |
| June 30, 2026 | 44.49 |
| June 29, 2026 | 45.07 |
| June 26, 2026 | 46.23 |
| June 25, 2026 | 42.90 |
| June 24, 2026 | 41.69 |
| June 23, 2026 | 40.39 |
| June 22, 2026 | 40.47 |
| June 18, 2026 | 40.10 |
| June 17, 2026 | 39.13 |
| June 16, 2026 | 38.46 |
| June 15, 2026 | 38.29 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Krystal Biotech, Inc. | 356.19 |
| AbbVie, Inc. | 457.82 |
| Marker Therapeutics, Inc. | 1.52 |
| TG Therapeutics, Inc. | 55.42 |
| ADMA Biologics, Inc. | 9.72 |